相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor organoid-T-cell coculture systems
Chiara M. Cattaneo et al.
NATURE PROTOCOLS (2020)
ST2 as checkpoint target for colorectal cancer immunotherapy
Kevin Van der Jeught et al.
JCI INSIGHT (2020)
The Contribution of Epigenetics to Cancer Immunotherapy
Lorea Villanueva et al.
TRENDS IN IMMUNOLOGY (2020)
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
Ludovica Grassi et al.
CELL DEATH & DISEASE (2019)
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
Gal Cafri et al.
NATURE COMMUNICATIONS (2019)
Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
Debarati Banik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
HDAC inhibitors tested in phase III trial
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
Nina D'Abreo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
Jumpei Kondo et al.
CELLS (2019)
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
Ik Sun Kim et al.
NATURE CELL BIOLOGY (2019)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti-Mays et al.
NPJ BREAST CANCER (2019)
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Nhan Phan et al.
COMMUNICATIONS BIOLOGY (2019)
Checkpoint blockade in the treatment of breast cancer: current status and future directions
Lironne Wein et al.
BRITISH JOURNAL OF CANCER (2018)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2018)
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis et al.
NATURE MEDICINE (2018)
Organoids predict clinical responses
Conor A. Bradley
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells
Alessandra Sacchi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity
Christopher Dravis et al.
CANCER CELL (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Organoid technology and applications in cancer research
Hanxiao Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
A model for tumor-immune interaction
Natalie de Souza
NATURE METHODS (2018)
Co-inhibition of mTORC1, HDAC and ESR1a retards the growth of triple-negative breast cancer and suppresses cancer stem cells
Andrew Sulaiman et al.
CELL DEATH & DISEASE (2018)
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal et al.
CELL (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
Yujing Li et al.
NATURE COMMUNICATIONS (2018)
Studying tumour-specific T cell responses in 3D
Kirsty Minton
NATURE REVIEWS IMMUNOLOGY (2018)
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2018)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing
Miguel Crespo et al.
NATURE MEDICINE (2017)
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
Sanja Stevanovic et al.
SCIENCE (2017)
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
Guan-Zhong Qiu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
HDAC inhibition potentiates immunotherapy in triple negative breast cancer
Manuela Terranova-Barberio et al.
ONCOTARGET (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Elena Ceccacci et al.
BRITISH JOURNAL OF CANCER (2016)
Targeting of phosphatidylserine by monoclonal antibodies augments the activity of immune checkpoint inhibitor PD-1/PD-L1 therapy in murine breast tumors
M. Gray et al.
CANCER RESEARCH (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Wei Yang et al.
NATURE (2016)
PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia
Robert S. Banh et al.
NATURE CELL BIOLOGY (2016)
Organoids as an in vitro model of human development and disease
Aliya Fatehullah et al.
NATURE CELL BIOLOGY (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
Michael J. Gray et al.
BREAST CANCER RESEARCH (2016)
TP53 loss creates therapeutic vulnerability in colorectal cancer
Yunhua Liu et al.
NATURE (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
Patrizia Leone et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
Richard Wu et al.
CANCER JOURNAL (2012)
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2
Nimanthi Jayathilaka et al.
NUCLEIC ACIDS RESEARCH (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
Re-oxygenation causes hypoxic tumor regression through restoration of p53 wild-type conformation and post-translational modifications
R. Gogna et al.
CELL DEATH & DISEASE (2012)
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
P. N. Munster et al.
BRITISH JOURNAL OF CANCER (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
Cheng-Jung Lai et al.
CANCER RESEARCH (2010)
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Toshiro Sato et al.
NATURE (2009)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
The role of TNF superfamily members in T-cell function and diseases
Michael Croft
NATURE REVIEWS IMMUNOLOGY (2009)
CD8+ T cell efficacy in vaccination and disease
Victor Appay et al.
NATURE MEDICINE (2008)
New dimensions in tumor immunology: what does 3D culture reveal?
Chantal Feder-Mengus et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
DAVID: Database for annotation, visualization, and integrated discovery
G Dennis et al.
GENOME BIOLOGY (2003)
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis
B Motyka et al.
CELL (2000)
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection
SRM Clarke et al.
IMMUNOLOGY AND CELL BIOLOGY (2000)
分享论文
